2'-Deoxyguanosine monohydrateCAS# 312693-72-4 |
2D Structure
Quality Control & MSDS
Package In Stock
Number of papers citing our products
Cas No. | 312693-72-4 | SDF | Download SDF |
PubChem ID | N/A | Appearance | Powder |
Formula | C10H13N5O4 | M.Wt | 267.25 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
2'-Deoxyguanosine monohydrate Dilution Calculator
2'-Deoxyguanosine monohydrate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.7418 mL | 18.7091 mL | 37.4181 mL | 74.8363 mL | 93.5454 mL |
5 mM | 0.7484 mL | 3.7418 mL | 7.4836 mL | 14.9673 mL | 18.7091 mL |
10 mM | 0.3742 mL | 1.8709 mL | 3.7418 mL | 7.4836 mL | 9.3545 mL |
50 mM | 0.0748 mL | 0.3742 mL | 0.7484 mL | 1.4967 mL | 1.8709 mL |
100 mM | 0.0374 mL | 0.1871 mL | 0.3742 mL | 0.7484 mL | 0.9355 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Gylongiposide I
Catalog No.:BCX1403
CAS No.:206876-12-2
- 4-Methoxy-2-[(6-O-β-D-xylopyranosyl-β-D-glucopyranosyl)oxy]benzaldehyde
Catalog No.:BCX1402
CAS No.:140484-68-0
- 7β-Hydroxyganoderenic acid F
Catalog No.:BCX1401
CAS No.:1245946-62-6
- 4,3',5'-Trihydroxyresveratrol
Catalog No.:BCX1400
CAS No.:637776-83-1
- Senecionine acetate
Catalog No.:BCX1399
CAS No.:126642-77-1
- Tapinarof
Catalog No.:BCX1398
CAS No.:79338-84-4
- 7α-Hydroxysarsasapogenin
Catalog No.:BCX1397
CAS No.:220832-70-2
- 7-Hydroxyisoflavone
Catalog No.:BCX1396
CAS No.:13057-72-2
- Elaidic acid
Catalog No.:BCX1395
CAS No.:112-79-8
- Smilagenin
Catalog No.:BCX1394
CAS No.:126-18-1
- 3-O-Acetylbufotalin
Catalog No.:BCX1393
CAS No.:4029-69-0
- Thevetin A
Catalog No.:BCX1392
CAS No.:37933-66-7
- Emetine hydrobromide
Catalog No.:BCX1405
CAS No.:52714-87-1
- 1β-Methoxydiversifolin 3-O-methyl ether
Catalog No.:BCX1406
CAS No.:194474-71-0
- 5-Alpha-Hydroxy Laxogenin
Catalog No.:BCX1407
CAS No.:56786-63-1
- Chitohexaose Hexahydrochloride
Catalog No.:BCX1408
CAS No.:127171-88-4
- Chitopentaose Pentahydrochloride
Catalog No.:BCX1409
CAS No.:117467-64-8
- Chitotetraose Tetrahydrochloride
Catalog No.:BCX1410
CAS No.:117399-50-5
- Chitobiose Dihydrochloride
Catalog No.:BCX1411
CAS No.:115350-24-8
- N,N',N'',N''',N'''',N'''''-Hexaacetyl chitohexaose
Catalog No.:BCX1412
CAS No.:38854-46-5
- N,N',N'',N''',N''''-Pentaacetyl chitopentaose
Catalog No.:BCX1413
CAS No.:36467-68-2
- N,N',N'',N'''-Tetraacetylchitotetraose
Catalog No.:BCX1414
CAS No.:2706-65-2
- N,N',N''-Triacetylchitotriose
Catalog No.:BCX1415
CAS No.:38864-21-0
- N,N'-Diacetylchitobiose
Catalog No.:BCX1416
CAS No.:35061-50-8
Optimal compatibility proportional screening of Trichosanthis Pericarpium - Trichosanthis Radix and its anti - Inflammatory components effect on experimental zebrafish and coughing mice.[Pubmed:37634750]
J Ethnopharmacol. 2024 Jan 30;319(Pt 1):117096.
ETHNOPHARMACOLOGICAL RELEVANCE: The herbal pair of Trichosanthis Pericarpium (TP) - Trichosanthis Radix (TR) can be seen in the famous formula "Beimu Gualou San". It is a commonly selected combination of medicinal herbs for the treatment of cough with lung heat. Both drugs are derived from Trichosanthes kirilowii Maxim, a medicinal plant known for its ability to clear heat, resolve phlegm, produce saliva, and alleviate dryness. However, the optimal combination ratio and active ingredients of TP-TR have yet to be determined. AIM OF THE STUDY: This study aims to investigate the optimal combination ratio of TP-TR and its anti-inflammatory active ingredients in cough treatment. MATERIALS AND METHODS: A zebrafish (Danio rerio) inflammatory injury model and response surface method were applied in the present study to determine the appropriate proportion of TP-TR. Chemical constituents in TP-TR were identified using HPLC-ELSD and UPLC-MS/MS methods. Subsequently, a cough mouse model was created using an ammonia solution to evaluate the effectiveness of the optimal TP-TR ratio. Network pharmacology and intestinal flora sequencing were used to validate the anti-inflammatory components of TP-TR. RESULTS: The herbal pair of TP - TR at the ratio of 1:2 showed an optimal anti-inflammatory effect, with a composite inflammatory factor score of 119.645 in the zebrafish experiment. TP-TR combination facilitated the dissolution of glutamine, inosine, cytosine, isoquercetin, and other substances. In the animal model, the TP-TR (1:2) treatment significantly reduced the frequency of coughs and prolonged cough latency compared to the model group. Results of the network pharmacology indicated that inflammatory-related factors such as TLR4, STAT3, EGFR, and AKT1 played crucial roles in cough treatment with TP-TR, consistent with the validation experiment. The 16s rDNA sequencing results revealed a significant increase in the abundance of Clostridia_UCG-014, Lachnospiraceae, Christenella, Ruminococcus, and other species in the intestinal tract of mice after modelling. TP-TR (1:2) reduced the abundance of pro-inflammatory flora such as Clostridium_UCG-014 and Lachnospira, which were closely associated with L-lysine and trans-4-hydroxy-L-proline present in TP-TR according to correlation analysis. CONCLUSION: TP-TR may promote the dissolution of glutamine, thymidine, inosine, cytosine, isoquercetin, and other components through their combination, thereby regulating the abundance of Clostridium_UCG-014 and Lachnospira and exerting an antitussive effect. This study, for the first time, showed that TP-TR at a 1:2 ratio exhibits superior anti-inflammatory effects. In addition to inflammatory mediators like EGFR, TLR4, AKT1, and STAT3, gut microbes could also serve as potential regulatory targets of TP-TR in the treatment of cough. 2'-Deoxyguanosine monohydrate, L-lysine, L-leucine, gamma-aminobutyric acid, L-valine, L-tryptophan, L-proline, trans-4-hydroxy-L-proline, L-methionine, uridine, 2'-deoxyinosine, guanosine, cucurbitacin B and cucurbitacin D were identified as its anti-inflammatory active ingredients.
Short communication: Nutrient consumption patterns of Lactobacillus acidophilus KLDS 1.0738 in controlled pH batch fermentations.[Pubmed:28501405]
J Dairy Sci. 2017 Jul;100(7):5188-5194.
This work focused on elucidating the nutrient consumption patterns of Lactobacillus acidophilus to guide the design of media for high-cell-density culture. We investigated the nutrient consumption patterns of L. acidophilus KLDS 1.0738 in chemically defined media in controlled pH batch fermentations. The most abundantly consumed amino acids, vitamins, ions, and purines and pyrimidines were Glu and Gly, pyridoxine and nicotinamide, K(+) and PO(4)(3-), and guanine and uracil, respectively. The highest consumption rates for amino acids, vitamins, ions, and purines and pyrimidines were Asp and Arg, folic acid and pyridoxine, Fe(2+) and Mn(2+), and uracil and thymine, respectively. Furthermore, most of the amino acids, as well as guanine, thymine, pyridoxine, folic acid, nicotinamide, Mg(2+), PO(4)(3-), and K(+) had the highest bioavailability from the end of the lag growth phase to the mid-exponential growth phase. The overall consumption of glucose, adenine nucleotides, 2'-deoxyguanosine monohydrate, calcium pantothenate, Fe(2+) and Mn(2+) decreased with increasing average growth rate, indicating more effective use of these nutritional components at a higher average growth rate, as biomass yield based on nutritional component consumption increased. Our findings help to formulate complex media for high-cell-density cultivation and provide a theoretical basis for L. acidophilus feeding strategies.